ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal

January 16, 2026 10:01 AM EST

The company logo for Kenvue Inc., Johnson & Johnson's consumer-health business, is displayed on a screen during the company's IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. REUTERS/Brendan McDermid

By Svea Herbst-Bayliss

Jan 16 (Reuters) - ⁠Institutional Shareholder ⁠Services ‍on Friday recommended that shareholders approve plans by Kleenex maker Kimberly-Clark to buy Tylenol maker ‍Kenvue, saying a tie-up could improve financial metrics.

"On balance, ​support for the transaction is warranted," wrote ISS, whose recommendations often ​guide how large investors vote on hot-button issues like mergers and who serves on boards. Shareholders will vote on January 29.

Kimberly-Clark in ​early November proposed buying Kenvue for more than $40 billion to create a global consumer health company with brands ​like Band-Aids and Huggies diapers.

Activist investors, including Toms Capital and Third Point, had ‌been pushing Kenvue to sell itself at the same time the company faced ongoing liability litigation ​over talcum-containing baby powder and ⁠warnings from the White House that the active ingredient in Tylenol could cause autism.

ISS, in ‌its note, acknowledged that a critical question for shareholders will be the "sustained negative market reaction" and uncertainties about the litigation revolving ‌around Kenvue products.

Kimberly-Clark's share price has dropped roughly 17% since the ‌deal was announced. Kenvue's share price has tumbled 35% since the former consumer healthcare division of Johnson & Johnson was listed as a ‍public company in 2023.

But ISS noted that a tie-up between Kimberly-Clark and Kenvue would bring ⁠positive synergies and benefits for the company's strategic goals. It also noted that it is positive that no shareholder has publicly criticized the planned deal.

(Reporting by Svea Herbst-BaylissEditing by Mark Potter and Louise Heavens)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Reuters

Related Entities

Third Point LLC